Stephanie Wesolowski
Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetus | 38 | 2025 | 803 | 5.790 |
Why?
| | Liver | 28 | 2025 | 1937 | 4.870 |
Why?
| | Sheep | 48 | 2025 | 854 | 4.690 |
Why?
| | Fetal Growth Retardation | 30 | 2025 | 557 | 4.630 |
Why?
| | Glucose | 24 | 2024 | 1018 | 3.940 |
Why?
| | Diet, Western | 12 | 2025 | 81 | 3.050 |
Why?
| | Placental Insufficiency | 16 | 2025 | 116 | 2.640 |
Why?
| | Hypoxia | 8 | 2025 | 1106 | 2.530 |
Why?
| | Insulin | 31 | 2025 | 2389 | 2.330 |
Why?
| | Pregnancy | 68 | 2025 | 6715 | 2.290 |
Why?
| | Liver Cirrhosis | 3 | 2025 | 316 | 2.180 |
Why?
| | Amino Acids | 15 | 2025 | 503 | 2.100 |
Why?
| | Fetal Development | 13 | 2025 | 296 | 1.980 |
Why?
| | Fetal Hypoxia | 4 | 2025 | 54 | 1.860 |
Why?
| | Prenatal Exposure Delayed Effects | 7 | 2025 | 606 | 1.810 |
Why?
| | Maternal Nutritional Physiological Phenomena | 5 | 2025 | 175 | 1.780 |
Why?
| | Maternal-Fetal Exchange | 5 | 2024 | 165 | 1.630 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2023 | 278 | 1.550 |
Why?
| | Gluconeogenesis | 9 | 2025 | 79 | 1.520 |
Why?
| | Muscle, Skeletal | 18 | 2025 | 1699 | 1.490 |
Why?
| | Metformin | 3 | 2024 | 327 | 1.480 |
Why?
| | Adaptation, Physiological | 4 | 2025 | 545 | 1.430 |
Why?
| | Animals | 83 | 2025 | 36915 | 1.340 |
Why?
| | Oxidation-Reduction | 8 | 2025 | 1059 | 1.290 |
Why?
| | Lactic Acid | 5 | 2024 | 306 | 1.240 |
Why?
| | Insulin Resistance | 11 | 2025 | 1187 | 1.180 |
Why?
| | Placenta | 10 | 2025 | 749 | 1.080 |
Why?
| | Pancreas | 7 | 2024 | 328 | 1.060 |
Why?
| | Hyperinsulinism | 4 | 2020 | 121 | 1.010 |
Why?
| | Placental Circulation | 4 | 2022 | 66 | 1.000 |
Why?
| | Female | 80 | 2025 | 72703 | 0.870 |
Why?
| | Bile Acids and Salts | 1 | 2025 | 199 | 0.830 |
Why?
| | Leucine | 7 | 2022 | 111 | 0.800 |
Why?
| | Glucose Clamp Technique | 4 | 2020 | 194 | 0.780 |
Why?
| | Leukocytes | 1 | 2024 | 311 | 0.770 |
Why?
| | Adipose Tissue | 5 | 2021 | 624 | 0.750 |
Why?
| | Insulin-Secreting Cells | 5 | 2024 | 372 | 0.720 |
Why?
| | Hypoglycemic Agents | 4 | 2024 | 1282 | 0.700 |
Why?
| | Glucagon | 6 | 2025 | 109 | 0.680 |
Why?
| | Primates | 5 | 2024 | 125 | 0.660 |
Why?
| | Disease Models, Animal | 11 | 2025 | 4281 | 0.660 |
Why?
| | Hepatocytes | 5 | 2024 | 220 | 0.620 |
Why?
| | Islets of Langerhans | 7 | 2024 | 803 | 0.610 |
Why?
| | Insulin-Like Growth Factor I | 6 | 2024 | 316 | 0.580 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2024 | 193 | 0.570 |
Why?
| | Blood Glucose | 10 | 2025 | 2161 | 0.550 |
Why?
| | Fetal Blood | 5 | 2024 | 327 | 0.540 |
Why?
| | Pregnancy Complications | 2 | 2019 | 521 | 0.530 |
Why?
| | Leptin | 5 | 2016 | 233 | 0.530 |
Why?
| | Lactation | 4 | 2024 | 184 | 0.510 |
Why?
| | Oxygen Consumption | 3 | 2025 | 681 | 0.500 |
Why?
| | Oxygen | 7 | 2023 | 943 | 0.500 |
Why?
| | Gestational Age | 7 | 2024 | 901 | 0.500 |
Why?
| | Energy Metabolism | 2 | 2021 | 892 | 0.440 |
Why?
| | Obesity | 7 | 2025 | 2966 | 0.420 |
Why?
| | Myoblasts | 3 | 2021 | 84 | 0.420 |
Why?
| | Gene Expression Regulation | 7 | 2025 | 2615 | 0.420 |
Why?
| | Mammary Glands, Animal | 3 | 2010 | 129 | 0.410 |
Why?
| | Lipid Metabolism | 6 | 2024 | 509 | 0.410 |
Why?
| | Macaca | 6 | 2025 | 55 | 0.400 |
Why?
| | Pyruvic Acid | 2 | 2024 | 54 | 0.400 |
Why?
| | Uterus | 3 | 2021 | 215 | 0.370 |
Why?
| | Mitochondria | 3 | 2024 | 938 | 0.370 |
Why?
| | Cell Proliferation | 5 | 2024 | 2471 | 0.360 |
Why?
| | Oxidative Stress | 3 | 2025 | 1302 | 0.360 |
Why?
| | RNA, Messenger | 8 | 2016 | 2837 | 0.350 |
Why?
| | Diet, High-Fat | 3 | 2023 | 248 | 0.340 |
Why?
| | Receptors, Leptin | 3 | 2008 | 23 | 0.320 |
Why?
| | Infusions, Intravenous | 6 | 2021 | 411 | 0.320 |
Why?
| | Cattle | 5 | 2016 | 982 | 0.300 |
Why?
| | Glucagon-Secreting Cells | 2 | 2024 | 24 | 0.270 |
Why?
| | Up-Regulation | 4 | 2017 | 846 | 0.270 |
Why?
| | Macaca mulatta | 2 | 2024 | 170 | 0.260 |
Why?
| | Uterine Artery | 2 | 2024 | 79 | 0.260 |
Why?
| | Gene Expression Profiling | 3 | 2019 | 1769 | 0.250 |
Why?
| | Hypoglycemia | 3 | 2014 | 442 | 0.250 |
Why?
| | Citrate (si)-Synthase | 2 | 2024 | 60 | 0.240 |
Why?
| | Muscle Development | 3 | 2021 | 111 | 0.240 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2021 | 216 | 0.230 |
Why?
| | Sheep, Domestic | 3 | 2019 | 34 | 0.230 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2024 | 2508 | 0.230 |
Why?
| | Linoleic Acids, Conjugated | 1 | 2014 | 8 | 0.230 |
Why?
| | Signal Transduction | 7 | 2024 | 5077 | 0.230 |
Why?
| | Mammals | 2 | 2023 | 286 | 0.230 |
Why?
| | Fatty Acids | 2 | 2023 | 443 | 0.220 |
Why?
| | Glycine | 2 | 2023 | 175 | 0.220 |
Why?
| | Stilbenes | 1 | 2014 | 36 | 0.220 |
Why?
| | Hindlimb | 3 | 2021 | 128 | 0.220 |
Why?
| | Milk | 1 | 2014 | 123 | 0.210 |
Why?
| | Fetal Heart | 1 | 2024 | 55 | 0.210 |
Why?
| | Mitochondria, Heart | 1 | 2024 | 100 | 0.210 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.210 |
Why?
| | Muscle Proteins | 3 | 2022 | 229 | 0.200 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2025 | 220 | 0.200 |
Why?
| | Macrophages | 3 | 2020 | 1547 | 0.200 |
Why?
| | Glutamine | 1 | 2023 | 104 | 0.200 |
Why?
| | Immunophenotyping | 1 | 2024 | 318 | 0.200 |
Why?
| | Serine | 1 | 2023 | 141 | 0.200 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 59 | 0.190 |
Why?
| | Blotting, Western | 3 | 2019 | 1227 | 0.190 |
Why?
| | Hypothalamus | 1 | 2003 | 153 | 0.190 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 16 | 0.190 |
Why?
| | Body Temperature Regulation | 1 | 2003 | 98 | 0.190 |
Why?
| | Dietary Fats | 1 | 2014 | 301 | 0.190 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 12 | 0.190 |
Why?
| | Gene Expression | 4 | 2023 | 1505 | 0.190 |
Why?
| | Bone Marrow | 1 | 2023 | 286 | 0.180 |
Why?
| | Malnutrition | 1 | 2012 | 82 | 0.180 |
Why?
| | Sympathetic Nervous System | 1 | 2012 | 181 | 0.180 |
Why?
| | Fatty Liver | 1 | 2014 | 239 | 0.180 |
Why?
| | Quantitative Trait Loci | 1 | 2004 | 381 | 0.180 |
Why?
| | Swine | 1 | 2004 | 775 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2019 | 854 | 0.180 |
Why?
| | Triglycerides | 2 | 2018 | 524 | 0.170 |
Why?
| | Mitochondrial Diseases | 1 | 2021 | 92 | 0.170 |
Why?
| | Phenotype | 3 | 2023 | 3201 | 0.170 |
Why?
| | Mitochondria, Liver | 1 | 2020 | 74 | 0.170 |
Why?
| | Male | 15 | 2025 | 67308 | 0.170 |
Why?
| | Fibrosis | 1 | 2023 | 552 | 0.160 |
Why?
| | Chorioamnionitis | 1 | 2020 | 42 | 0.160 |
Why?
| | Maternal Exposure | 1 | 2021 | 188 | 0.160 |
Why?
| | Altitude | 1 | 2024 | 479 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 974 | 0.160 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 398 | 0.160 |
Why?
| | Organ Size | 4 | 2021 | 479 | 0.160 |
Why?
| | Sexual Maturation | 2 | 2008 | 55 | 0.160 |
Why?
| | Glycolysis | 1 | 2021 | 319 | 0.160 |
Why?
| | Protein Biosynthesis | 2 | 2017 | 430 | 0.160 |
Why?
| | Acidosis | 1 | 2020 | 101 | 0.150 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 22 | 0.150 |
Why?
| | Antioxidants | 1 | 2023 | 577 | 0.150 |
Why?
| | Drug Administration Schedule | 4 | 2021 | 784 | 0.150 |
Why?
| | Humans | 17 | 2025 | 136899 | 0.150 |
Why?
| | STAT3 Transcription Factor | 1 | 2010 | 202 | 0.150 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2016 | 32 | 0.150 |
Why?
| | Genomics | 1 | 2004 | 790 | 0.150 |
Why?
| | Embryo, Mammalian | 1 | 2019 | 232 | 0.150 |
Why?
| | Stem Cells | 1 | 2022 | 589 | 0.140 |
Why?
| | Cell Division | 2 | 2017 | 795 | 0.140 |
Why?
| | Anemia | 2 | 2017 | 171 | 0.140 |
Why?
| | Cytokines | 3 | 2014 | 2078 | 0.140 |
Why?
| | Estradiol | 2 | 2010 | 513 | 0.140 |
Why?
| | Metabolic Diseases | 1 | 2018 | 108 | 0.140 |
Why?
| | Oxidative Phosphorylation | 3 | 2024 | 193 | 0.140 |
Why?
| | Glucose Intolerance | 1 | 2018 | 146 | 0.140 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 145 | 0.130 |
Why?
| | Adiponectin | 1 | 2018 | 241 | 0.130 |
Why?
| | Hydrocortisone | 4 | 2020 | 317 | 0.130 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2016 | 59 | 0.130 |
Why?
| | Models, Animal | 3 | 2024 | 387 | 0.130 |
Why?
| | Random Allocation | 3 | 2012 | 357 | 0.120 |
Why?
| | Proteins | 1 | 2012 | 1012 | 0.120 |
Why?
| | Lactates | 1 | 2015 | 85 | 0.120 |
Why?
| | Lower Extremity | 1 | 2019 | 423 | 0.120 |
Why?
| | Glucose-6-Phosphatase | 3 | 2016 | 33 | 0.120 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 35 | 0.110 |
Why?
| | Hyperglycemia | 1 | 2018 | 344 | 0.110 |
Why?
| | Transcription Factors | 2 | 2014 | 1715 | 0.110 |
Why?
| | Growth Hormone | 3 | 2016 | 101 | 0.110 |
Why?
| | Blotting, Northern | 2 | 2004 | 199 | 0.100 |
Why?
| | Epithelial Cells | 2 | 2008 | 1097 | 0.100 |
Why?
| | Infant, Newborn | 3 | 2024 | 6043 | 0.100 |
Why?
| | Inflammation | 2 | 2020 | 2817 | 0.100 |
Why?
| | Animal Feed | 2 | 2021 | 53 | 0.100 |
Why?
| | Breast Feeding | 1 | 2016 | 439 | 0.100 |
Why?
| | Transcriptome | 1 | 2019 | 973 | 0.100 |
Why?
| | Chromosome Mapping | 2 | 2004 | 523 | 0.100 |
Why?
| | Regional Blood Flow | 2 | 2024 | 474 | 0.090 |
Why?
| | Epigenesis, Genetic | 1 | 2016 | 658 | 0.090 |
Why?
| | Fetal Weight | 2 | 2021 | 56 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 4148 | 0.090 |
Why?
| | Mice | 6 | 2022 | 17775 | 0.090 |
Why?
| | Polymerase Chain Reaction | 2 | 2004 | 1061 | 0.080 |
Why?
| | Glycogen | 2 | 2016 | 55 | 0.080 |
Why?
| | Mice, Obese | 2 | 2018 | 66 | 0.080 |
Why?
| | Phosphorylation | 3 | 2020 | 1762 | 0.080 |
Why?
| | Tissue Distribution | 2 | 2012 | 330 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2020 | 437 | 0.080 |
Why?
| | Dietary Supplements | 2 | 2014 | 560 | 0.070 |
Why?
| | Gastrointestinal Microbiome | 1 | 2016 | 689 | 0.070 |
Why?
| | Inflammation Mediators | 2 | 2012 | 514 | 0.070 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2012 | 36 | 0.070 |
Why?
| | Animal Nutritional Physiological Phenomena | 2 | 2008 | 14 | 0.070 |
Why?
| | Down-Regulation | 2 | 2017 | 658 | 0.070 |
Why?
| | Liver Glycogen | 2 | 2016 | 17 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 2066 | 0.070 |
Why?
| | Biological Transport | 2 | 2020 | 416 | 0.060 |
Why?
| | Immunity, Innate | 2 | 2023 | 832 | 0.060 |
Why?
| | Lactalbumin | 1 | 2014 | 2 | 0.060 |
Why?
| | Receptors, Glucagon | 1 | 2025 | 28 | 0.060 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 24 | 0.060 |
Why?
| | Milk Proteins | 1 | 2014 | 34 | 0.060 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 58 | 0.060 |
Why?
| | Lipogenesis | 1 | 2014 | 60 | 0.060 |
Why?
| | RNA | 2 | 2008 | 924 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 100 | 0.050 |
Why?
| | Contraindications | 1 | 2014 | 90 | 0.050 |
Why?
| | Amniotic Fluid | 1 | 2024 | 95 | 0.050 |
Why?
| | Gene Order | 1 | 2003 | 26 | 0.050 |
Why?
| | Expressed Sequence Tags | 1 | 2003 | 42 | 0.050 |
Why?
| | Computer Systems | 1 | 2003 | 45 | 0.050 |
Why?
| | Animals, Inbred Strains | 1 | 2012 | 7 | 0.050 |
Why?
| | Receptors, Neuropeptide Y | 1 | 2012 | 1 | 0.050 |
Why?
| | Sympathetic Fibers, Postganglionic | 1 | 2012 | 4 | 0.050 |
Why?
| | Neuropeptide Y | 1 | 2012 | 14 | 0.050 |
Why?
| | Glucose Transporter Type 2 | 1 | 2012 | 12 | 0.050 |
Why?
| | Ceramides | 1 | 2023 | 113 | 0.050 |
Why?
| | Macrophage Activation | 1 | 2014 | 201 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2014 | 353 | 0.050 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2012 | 75 | 0.050 |
Why?
| | Cell Size | 1 | 2012 | 91 | 0.050 |
Why?
| | Electrolytes | 1 | 2012 | 59 | 0.050 |
Why?
| | Hepatitis | 1 | 2012 | 48 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2003 | 413 | 0.050 |
Why?
| | Solutions | 1 | 2012 | 170 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 10313 | 0.050 |
Why?
| | Acid-Base Equilibrium | 1 | 2012 | 28 | 0.050 |
Why?
| | Apoptosis | 2 | 2019 | 2542 | 0.050 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 163 | 0.050 |
Why?
| | Blood Gas Analysis | 1 | 2012 | 74 | 0.050 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 121 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2016 | 2416 | 0.050 |
Why?
| | Mice, SCID | 1 | 2022 | 367 | 0.050 |
Why?
| | Carbon Isotopes | 1 | 2012 | 142 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 191 | 0.050 |
Why?
| | Time Factors | 2 | 2012 | 6802 | 0.050 |
Why?
| | Proteolysis | 1 | 2012 | 179 | 0.050 |
Why?
| | Infusion Pumps | 1 | 2021 | 32 | 0.050 |
Why?
| | Hormones | 1 | 2012 | 143 | 0.050 |
Why?
| | Arginine | 1 | 2012 | 274 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 344 | 0.040 |
Why?
| | Birth Weight | 1 | 2024 | 514 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5766 | 0.040 |
Why?
| | Placentation | 1 | 2021 | 45 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 765 | 0.040 |
Why?
| | Fetal Macrosomia | 1 | 2021 | 62 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 601 | 0.040 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 72 | 0.040 |
Why?
| | Receptors, Nicotinic | 1 | 2012 | 338 | 0.040 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 80 | 0.040 |
Why?
| | Carbon Dioxide | 1 | 2012 | 267 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2014 | 703 | 0.040 |
Why?
| | Drug Synergism | 1 | 2020 | 379 | 0.040 |
Why?
| | Pregnancy, Animal | 1 | 2019 | 53 | 0.040 |
Why?
| | Fetal Diseases | 1 | 2021 | 171 | 0.040 |
Why?
| | Norepinephrine | 1 | 2020 | 212 | 0.040 |
Why?
| | Body Weight | 1 | 2004 | 973 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 153 | 0.040 |
Why?
| | Kinetics | 1 | 2012 | 1679 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2003 | 2901 | 0.040 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 24 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2008 | 145 | 0.040 |
Why?
| | Dairying | 1 | 2007 | 7 | 0.040 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2008 | 86 | 0.040 |
Why?
| | Cell Count | 1 | 2018 | 321 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2008 | 117 | 0.030 |
Why?
| | Receptor, Insulin | 1 | 2007 | 105 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2004 | 1458 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2007 | 154 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2008 | 119 | 0.030 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 310 | 0.030 |
Why?
| | Apolipoproteins B | 1 | 2016 | 43 | 0.030 |
Why?
| | Ovariectomy | 1 | 2007 | 150 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 2007 | 536 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2020 | 882 | 0.030 |
Why?
| | Temperature | 1 | 2019 | 680 | 0.030 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2006 | 21 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1460 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 844 | 0.030 |
Why?
| | Diet | 1 | 2014 | 1261 | 0.030 |
Why?
| | Thyroid Hormones | 1 | 2016 | 58 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2008 | 371 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2016 | 85 | 0.030 |
Why?
| | Exons | 1 | 2016 | 349 | 0.030 |
Why?
| | Luteinizing Hormone | 1 | 2016 | 185 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2008 | 480 | 0.030 |
Why?
| | Carbon Radioisotopes | 1 | 2014 | 35 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2010 | 2182 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2016 | 377 | 0.030 |
Why?
| | Genome | 1 | 2016 | 292 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1108 | 0.030 |
Why?
| | Receptors, Cell Surface | 1 | 2006 | 391 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2008 | 771 | 0.030 |
Why?
| | Blood Transfusion | 1 | 2016 | 324 | 0.030 |
Why?
| | Eating | 1 | 2016 | 380 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2008 | 1242 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2014 | 248 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2010 | 4204 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1906 | 0.020 |
Why?
| | Genetic Variation | 1 | 2016 | 986 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1773 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 692 | 0.020 |
Why?
| | Cell Line | 1 | 2006 | 2847 | 0.020 |
Why?
| | Adult | 2 | 2024 | 37595 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 26 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 44 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2175 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 13157 | 0.020 |
Why?
| | Algorithms | 1 | 2014 | 1695 | 0.020 |
Why?
| | Adolescent | 1 | 2023 | 21402 | 0.010 |
Why?
|
|
Wesolowski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|